协同抑制细胞生长:通过混合计算方法揭示的miazine衍生物针对p53和MDM2
Srinivasan M1, Ismail Y1, Irfan N1
1Crescent School of Pharmacy. B.S Abdur Rahman Crescent Institute of Science and Technology, Chennai, Tamil Nadu, India.
Computational biology and chemistry
|January 17, 2025
概括
研究人员设计了新型的miazine衍生物来抑制驱动肺癌生长的关键蛋白质. 这些化合物显示出作为有效的分子开发新的肺癌治疗方法的希望.
科学领域:
- 在瘤学瘤学.
- 药用化学 医学化学
- 计算生物学 计算生物学
背景情况:
- 肺癌仍然是全球癌症死亡的主要原因.
- 遗传和表观遗传改变驱动癌细胞的增殖.
- 针对p53和MDM2等关键蛋白质是癌症治疗的关键策略.
研究的目的:
- 设计和合成新型miazine衍生物作为p53和MDM2蛋白的潜在抑制剂.
- 用计算方法评估设计分子的结合亲和力和稳定性.
- 确定有希望的化合物,用于开发新的肺癌治疗方法.
主要方法:
- 基于功能组的药物设计被用来创建phenmiazine环线索.
- 进行了分子对接模拟 (glide dock),以评估与p53 (7A1W) 和MDM2 (7AU9) 蛋白质的结合.
- 分子力学概括天生的表面积 (MMGBSA) 用于计算结合能.
- 进行了分子动力学 (MD) 模拟和密度功能紧密结合 (DFTB) 研究,以确认稳定性和化学性质.
主要成果:
- 一百个miazine分子被设计和对接.
- 对于一个氨基酸替代分子,所获得的最佳结合能量是-8.16 kcal/mol.
- MD模拟证实了该复合物的稳定性,其中关键相互作用涉及9个氨基酸 (疏水和键).
- DFTB分析表明显著的分子稳定性,能量差距为0.0508.
结论:
- miazine环衍生物对p53和MDM2具有强大的抑制活性.
- 设计的aminobenzoic acid替代的phenmiazine衍生物显示出出色的结合亲和力和稳定性.
- 这些发现表明,miazine衍生物是消除肺癌的有希望的化合物.
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Negative Regulator Molecules
35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K


